| 000 | 01791 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515065716.0 | ||
| 264 | 0 | _c20070809 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.10783 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZaccaria, Alfonso | |
| 245 | 0 | 0 |
_aPersistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. _h[electronic resource] |
| 260 |
_bHaematologica _cApr 2007 |
||
| 300 |
_a564-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAneuploidy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aChromosome Deletion |
| 650 | 0 | 4 |
_aClone Cells _xpathology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMonosomy |
| 650 | 0 | 4 | _aNeoplastic Cells, Circulating |
| 650 | 0 | 4 | _aPhiladelphia Chromosome |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTrisomy |
| 700 | 1 | _aValenti, Anna Maria | |
| 700 | 1 | _aDonti, Emilio | |
| 700 | 1 | _aGozzetti, Alessandro | |
| 700 | 1 | _aRonconi, Sonia | |
| 700 | 1 | _aSpedicato, Francesco | |
| 773 | 0 |
_tHaematologica _gvol. 92 _gno. 4 _gp. 564-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.10783 _zAvailable from publisher's website |
| 999 |
_c17034679 _d17034679 |
||